0001567619-15-001060.txt : 20150805 0001567619-15-001060.hdr.sgml : 20150805 20150805211202 ACCESSION NUMBER: 0001567619-15-001060 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150804 FILED AS OF DATE: 20150805 DATE AS OF CHANGE: 20150805 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: vTv Therapeutics Inc. CENTRAL INDEX KEY: 0001641489 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473916571 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4170 MENDENHALL OAKS PKWY CITY: HIGH POINT STATE: NC ZIP: 27265 BUSINESS PHONE: 336-841-0300 MAIL ADDRESS: STREET 1: 4170 MENDENHALL OAKS PKWY CITY: HIGH POINT STATE: NC ZIP: 27265 FORMER COMPANY: FORMER CONFORMED NAME: VTV Therapeutics Inc. DATE OF NAME CHANGE: 20150506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERELMAN RONALD O CENTRAL INDEX KEY: 0001186472 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37524 FILM NUMBER: 151030792 MAIL ADDRESS: STREET 1: 35 EAST 62ND STREET CITY: NEW YORK STATE: NY ZIP: 10021 4 1 s000988x7_form4.xml OWNERSHIP DOCUMENT X0306 4 2015-08-04 0 0001641489 vTv Therapeutics Inc. VTVT 0001186472 PERELMAN RONALD O C/O MACANDREWS & FORBES INCORPORATED 35 EAST 62ND STREET NEW YORK NY 10065 0 0 1 0 Class A common stock 2015-08-04 4 P 0 40000 10.0021 A 1706666 I See footnote. Class A common stock 2015-08-04 4 P 0 30000 10.00 A 1736666 I See footnote. Class A common stock 2015-08-05 4 P 0 30000 9.9979 A 1766666 I See footnote. The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.99 to $10.05, inclusive, on August 3, 2015, prior to the closing of the Issuer's initial public offering. The reporting person undertakes to provide to vTv Therapeutics Inc., any security holder of vTv Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in footnotes 1 and 3 to this Form 4. Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"), which holds the securities described above. Mr. Perelman, M&F Inc., M&F LLC and M&F Group may be deemed to be directors by deputization of the Issuer by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of vTv Therapeutics Holdings LLC, an indirect subsidiary of M&F Inc. ("Holdings"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and Holdings. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $10.00, inclusive. /s/ Barry F. Schwartz, attorney-in-fact 2015-08-05